The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
暂无分享,去创建一个
W. Lehmacher | C. Seitz | M. Meurer | U. Müller-Ladner | F. Reichenberger | S. Karrer | M. Worm | E. Schulze-Lohoff | C. Fiehn | K. Reich | T. Krieg | M. Haust | A. Kuhn | A. Rubbert | K. Scharffetter-Kochanek | R. Stadler | R. Szeimies | R. Szeimies | N. Hunzelmann | H. Lorenz | R. Hein | G. Fierlbeck | G. Riemekasten | N. Blank | P. Saar | P. Moinzadeh | C. Sunderkoetter | E. Aberer | A. Juche | I. Foeldvari | E. Genth | W. Gross | K. Steinbrink | C. Pfeiffer | E. Schmidt | I. Melchers | R. Hinrichs | M. Weber | I. Kötter | M. Böhm | Manfred Weber | G. Bali | P. Klaus | E. Schmidt | P. Lehmann | A. Müller | B. Grundt | K. Walker | M. Böhm | K. Gräfenstein | V. Bartels | K. M. Walker | A. Müller | R. Stadler | T. Krieg | U. Müller-Ladner | G. Fierlbeck | Nicolas Hunzelmann | W. Gross | I. Kötter | C. Seitz | Pia Moinzadeh | C. Sunderkoetter | P. Moinzadeh
[1] V. Steen. The many faces of scleroderma. , 2008, Rheumatic diseases clinics of North America.
[2] M. Hudson,et al. The development of systemic sclerosis classification criteria , 2007, Clinical Rheumatology.
[3] U. Müller-Ladner,et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database , 2007, Annals of the rheumatic diseases.
[4] G. Riemekasten,et al. [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[5] G. Riemekasten,et al. Raynaud-Phänomen in der Dermatologie , 2006, Der Hautarzt.
[6] J. Ioannidis,et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. , 2005, The American journal of medicine.
[7] K. Takehara,et al. Epidemiological study of patients with systemic sclerosis in Tokyo , 2004, Archives of Dermatological Research.
[8] Brenda W Gillespie,et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. , 2003, Arthritis and rheumatism.
[9] M. Mayes. Scleroderma epidemiology. , 2003, Rheumatic diseases clinics of North America.
[10] S. Bombardieri,et al. Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.
[11] U. Haustein. Systemic sclerosis-scleroderma. , 2002, Dermatology online journal.
[12] T. Medsger,et al. Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.
[13] M. Mayes,et al. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. , 2001, Arthritis and rheumatism.
[14] G. Alarcón. Unclassified or undifferentiated connective tissue disease. , 2000, Bailliere's best practice & research. Clinical rheumatology.
[15] T. Medsger,et al. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. , 2000, Arthritis and rheumatism.
[16] P. Lachenbruch,et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. , 1998, The Journal of rheumatology.
[17] T. Medsger,et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. , 1997, Arthritis and rheumatism.
[18] A. Silman,et al. Epidemiology of systemic sclerosis. , 1996, Current opinion in rheumatology.
[19] Richard W. Martin,et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. , 1995, The Journal of rheumatology.
[20] K. Steinsson,et al. Systemic sclerosis in Iceland. A nationwide epidemiological study. , 1994, Annals of the rheumatic diseases.
[21] T. Medsger,et al. Epidemiology and natural history of systemic sclerosis. , 1990, Rheumatic diseases clinics of North America.
[22] R. Bennett. Scleroderma overlap syndromes. , 1990, Rheumatic diseases clinics of North America.
[23] M. Weinrich,et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. , 1989, Arthritis and rheumatism.
[24] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[25] M. Vatti,et al. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. , 1986, The Journal of rheumatology.
[26] L. Elveback,et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. , 1985, Mayo Clinic proceedings.
[27] H. Hatano. [Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis and polymyositis) in Japan]. , 1982, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[28] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[29] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.
[30] H. Maricq,et al. Undifferentiated connective tissue syndromes. , 1980, Arthritis and rheumatism.
[31] A. Masi,et al. Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.
[32] G. Rodnan,et al. Progressive systemic sclerosis sine scleroderma. , 1962, JAMA.